BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27723957)

  • 1. Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva.
    Schönfelder M; Hofmann H; Schulz T; Engl T; Kemper D; Mayr B; Rautenberg C; Oberhoffer R; Thieme D
    Drug Test Anal; 2016 Nov; 8(11-12):1186-1196. PubMed ID: 27723957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: suitability as a potential screening parameter in doping control.
    Thieme D; Rautenberg C; Grosse J; Schoenfelder M
    Drug Test Anal; 2013; 5(11-12):819-25. PubMed ID: 24167110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports.
    Ponzetto F; Mehl F; Boccard J; Baume N; Rudaz S; Saugy M; Nicoli R
    Anal Bioanal Chem; 2016 Jan; 408(3):705-19. PubMed ID: 26677027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of testosterone to epitestosterone ratio to horse urine - a complementary approach to detect the administrations of testosterone and its pro-drugs in Thoroughbred geldings.
    Viljanto M; Scarth J; Hincks P; Hillyer L; Cawley A; Suann C; Noble G; Walker CJ; Kicman AT; Parkin MC
    Drug Test Anal; 2017 Sep; 9(9):1328-1336. PubMed ID: 27717154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping control analysis of anabolic steroids in equine urine by gas chromatography-tandem mass spectrometry.
    Wong ASY; Leung GNW; Leung DKK; Wan TSM
    Drug Test Anal; 2017 Sep; 9(9):1320-1327. PubMed ID: 27607540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling.
    Mezzullo M; Fazzini A; Gambineri A; Di Dalmazi G; Mazza R; Pelusi C; Vicennati V; Pasquali R; Pagotto U; Fanelli F
    Clin Chem Lab Med; 2017 Aug; 55(9):1315-1323. PubMed ID: 28076306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of salivary cortisol and testosterone assays in chimpanzees by liquid chromatography-tandem mass spectrometry.
    Kutsukake N; Ikeda K; Honma S; Teramoto M; Mori Y; Hayasaka I; Yamamoto R; Ishida T; Yoshikawa Y; Hasegawa T
    Am J Primatol; 2009 Aug; 71(8):696-706. PubMed ID: 19452511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
    Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
    Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary testosterone measurement by liquid chromatography tandem mass spectrometry in adult males and females.
    Keevil BG; MacDonald P; Macdowall W; Lee DM; Wu FC;
    Ann Clin Biochem; 2014 May; 51(Pt 3):368-78. PubMed ID: 24194586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of musk administration on the doping test.
    He Y; Wang J; Liu X; Xu Y; He Z
    Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Badoud F; Boccard J; Schweizer C; Pralong F; Saugy M; Baume N
    J Steroid Biochem Mol Biol; 2013 Nov; 138():222-35. PubMed ID: 23796409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of Urinary and Serum Steroid Metabolites in Response to Testosterone Administration in Healthy Women.
    Elings Knutsson J; Andersson A; Baekken LV; Pohanka A; Ekström L; Hirschberg AL
    J Clin Endocrinol Metab; 2021 Mar; 106(3):697-707. PubMed ID: 33274381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application.
    Gessner L; Thevis M; Rothschild MA; Jübner M
    Drug Test Anal; 2022 Oct; 14(10):1744-1761. PubMed ID: 35947101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a liquid chromatography tandem mass spectrometry method for simultaneous determination of salivary melatonin, cortisol and testosterone.
    Jensen MA; Hansen AM; Abrahamsson P; Nørgaard AW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2527-32. PubMed ID: 21803007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of salivary testosterone and androstendione by liquid chromatography-tandem mass spectrometry.
    Turpeinen U; Hämäläinen E; Haanpää M; Dunkel L
    Clin Chim Acta; 2012 Mar; 413(5-6):594-9. PubMed ID: 22178818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
    Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administration.
    Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
    Drug Test Anal; 2018 May; 10(5):821-831. PubMed ID: 29148228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of saliva steroid profiling for the detection of endogenous steroid abuse: Reference thresholds for oral fluid steroid concentrations and ratios.
    Polet M; De Wilde L; Van Renterghem P; Van Gansbeke W; Van Eenoo P
    Anal Chim Acta; 2018 Jan; 999():1-12. PubMed ID: 29254559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.